Skip to content

Effect NMES on physical performance in frail elderly during hospitalization.

The effect of neuromuscular electrostimulation on muscle strenghthening of the m. quadriceps and on physical performance in frail elderly with poor physical performance on <day 4 of hospital admission.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23142
Enrollment
30
Registered
2014-10-03
Start date
2014-09-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular electrical stimulation Physical performance Frail elderly Hospital admission Sarcopenia Neuromusculaire electrostimulatie Fysiek functioneren Kwetsbare ouderen Ziekenhuisopname Sarcopenie

Interventions

Neuromuscular electrostimulation of the m. quadriceps

Sponsors

No sponsors
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Frail elderly (defined by the GFI score, GFI > 3), 70 years and above, with a SPPB <6 on day <4 day after admission to the geriatric ward, duration of admission at least 7 days.

Exclusion criteria

Exclusion criteria: - Bound to a wheelchair before admission - Terminal illness - Pain in the lower body which makes mobilisation impossible - No recovery of the underlying illness on day 4 of admission in comparison with the first day after admission - Presence of a pacemaker or ICD - Impossibility to give the patient instructions concerning the NMES and his measurements - Presence of an amputated leg or hemiparese

Design outcomes

Primary

MeasureTime frame
Short physical performance battery HABAM Knee extension Muscle mass of the upper leg (m. quadriceps) determined by the use of the Maltron Bioscan 920-II

Secondary

MeasureTime frame
Tolerance of NMES and side effects. Admission time in days Destination of dismissal; home or to a health facility Mortality

Contacts

Public ContactJ. Schaekens

Orbis Medisch Centrum Dr. H van der Hoffplein 1

J.Schaekens@orbisconcern.nl088-4597777

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)